Citation Impact
Citing Papers
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Identification of the translocation breakpoints in the Ts65Dn and Ts1Cje mouse lines: relevance for modeling down syndrome
2011
Synthesis of metallic nanoparticles using plant extracts
2013 Standout
The present and future of nanotechnology in human health care
2007
Advances in the Management of Digoxin Toxicity in the Older Patient
1997
Effect of Surface Properties on Nanoparticle–Cell Interactions
2009 Standout
Percutaneous coronary intervention: recommendations for good practice and training
2005
Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?
2016 Standout
Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications
2004 Standout
Biodegradable nanoparticles for drug and gene delivery to cells and tissue
2003 Standout
Cushing's syndrome
2015 Standout
PLGA-based nanoparticles: An overview of biomedical applications
2012 Standout
HRS Expert Consensus Statement on the Diagnosis and Management of Arrhythmias Associated With Cardiac Sarcoidosis
2014 Standout
Hydrogel nanoparticles in drug delivery
2008 Standout
Regulation of tissue perfusion in mammals by hypoxia‐inducible factor 1
2007 StandoutNobel
Cardiac Sarcoidosis
2004
Biodegradable polymeric nanoparticles based drug delivery systems
2009 Standout
Prevalence of congenital heart disease
2004 Standout
Spinal epidural hematoma complicating thrombolytic therapy with tissue plasminogen activator—a case report
2002
Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues
2008 Standout
Hypoxia-Inducible Factor 1α Polymorphism and Coronary Collaterals in Patients With Ischemic Heart Disease
2005 StandoutNobel
Risk factors and metabolic mechanisms in the pathogenesis of uraemic cardiac disease
2010
Coronary collateral circulation: Clinical significance and influence on survival in patients with coronary artery occlusion
1989
The Role of Actigraphy in the Study of Sleep and Circadian Rhythms
2003 Standout
A naturalistic investigation of the effects of day-long consumption of tea, coffee and water on alertness, sleep onset and sleep quality
2000
Does the Arterial Cannulation Site for Circulatory Arrest Influence Stroke Risk?
2004
Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy
2009 Standout
Nanoparticle-based targeted drug delivery
2009 Standout
Down syndrome
2020 Standout
Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy
2020 Standout
Succinate dehydrogenase (SDHx) mutations in pituitary tumors: could this be a new role for mitochondrial complex II and/or Krebs cycle defects?
2012
Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects
1992 Standout
Moderately hypothermic cardiopulmonary bypass and selective cerebral perfusion in ascending aorta and aortic arch surgery. Preliminary experience in twenty-two patients
1998
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Oxygen homeostasis
2009 StandoutNobel
Straight Deep Hypothermic Arrest: Experience in 394 Patients Supports Its Effectiveness as a Sole Means of Brain Preservation
2007
The integrated stress response
2016 Standout
Rolipram, a type IV-specific phosphodiesterase inhibitor, facilitates the establishment of long-lasting long-term potentiation and improves memory
1998 StandoutNobel
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Long-term results of percutaneous aortic valvuloplasty compared with aortic valve replacement in patients more than 75 years old
1992
ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context
2012 Standout
Use of clays as drug delivery systems: Possibilities and limitations
2006 Standout
Indications for Cardiac Catheterization and Intervention in Pediatric Cardiac Disease
2011 Standout
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015 Standout
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Actions of Caffeine in the Brain with Special Reference to Factors That Contribute to Its Widespread Use
1999 Standout
Three-year outcome after balloon aortic valvuloplasty. Insights into prognosis of valvular aortic stenosis.
1994
Biodegradable nanoparticles for drug and gene delivery to cells and tissue
2012
Controlled Ring-Opening Polymerization of Lactide and Glycolide
2004 Standout
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008 Standout
Intermediate-term effectiveness of balloon valvuloplasty for congenital aortic stenosis. A prospective follow-up study.
1991
Inorganic Nanoparticles for MRI Contrast Agents
2009 Standout
Works of J C Potier being referenced
Serum Digoxin Levels Related to Plasma Propafenone Levels During Concomitant Treatment
1991
SIPPLE'S SYNDROME ASSOCIATED WITH A LARGE PROLACTINOMA
1987
Direct coronary stenting without balloon predilation in acute coronary syndromes
1999
Angioplasty of chronic totally occluded coronary arteries: Usefulness of retrograde opacification of the distal part of the occluded vessel via the contralateral coronary artery
1987
Atlas of Genetics and Cytogenetics in Oncology and Haematology in 2013
2012
Short-term clinical and haemodynamic assessment of balloon aortic valvuloplasty in 30 elderly patients. Discrepancy between immediate and eighth-day haemodynamic values
1988
Attentional effects of caffeine in man: Comparison with drugs acting upon performance
1988
[Cardiac sarcoidosis responsible for localized left ventricular ectasia and refractory ventricular tachycardia. Anatomoclinical study].
1990
Peritoneal ultrafiltration and refractory congestive heart failure.
1997
Pharmacological Approaches to the Prevention of Restenosis After Coronary Angioplasty
1998
[ST segment elevation in anterior precordial leads and right ventricular infarction. Apropos of 6 cases].
1992
[Aneurysms of the aortic arch].
1968
Percutaneous balloon dilatation of calcific aortic valve stenosis: anatomical and haemodynamic evaluation.
1988